Hospital-acquired respiratory viral infections while applying droplet precautions on-site (DroPS) - prospective observation during the 2019/20 influenza season, Bern, Switzerland

IF 1.8 Q3 INFECTIOUS DISEASES

Infection Prevention in Practice Pub Date : 2024-07-26 DOI:10.1016/j.infpip.2024.100386

Michèle Birrer , Katrien Draps , Fabienne Hobi , Marianne Laguardia , Eveline Hofmann , Martin Luginbühl , Martin Perrig , Drahomir Aujesky , Jonas Marschall , Rami Sommerstein

{"title":"Hospital-acquired respiratory viral infections while applying droplet precautions on-site (DroPS) - prospective observation during the 2019/20 influenza season, Bern, Switzerland","authors":"Michèle Birrer , Katrien Draps , Fabienne Hobi , Marianne Laguardia , Eveline Hofmann , Martin Luginbühl , Martin Perrig , Drahomir Aujesky , Jonas Marschall , Rami Sommerstein","doi":"10.1016/j.infpip.2024.100386","DOIUrl":null,"url":null,"abstract":"<div><p>Single room isolation for respiratory viral infections (RVI), like influenza, puts hospitals under pressure. During the influenza season 2019/20, we implemented <em>Droplet precautions on-site</em> (DroPS) for RVI in two acute care hospitals and prospectively assessed the rate of hospital-acquired RVI (HARVI). 318 patients were admitted with RVI, 85 had Influenza or RSV, 75 stayed in multi-bed rooms with DroPS. From 764 patients <em>at risk</em>, hospitalised ≥ three days in a multi-bed room<em>,</em> 11 (1.4%) developed a clinical HARVI, and three tested positive (3/764, 0.4%; 2x RSV, 1x influenza). DroPS may represent an alternative strategy to deal with respiratory viral infections.</p></div>","PeriodicalId":33492,"journal":{"name":"Infection Prevention in Practice","volume":"6 3","pages":"Article 100386"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590088924000507/pdfft?md5=080f9af36a9f99f276333294824106dd&pid=1-s2.0-S2590088924000507-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Prevention in Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590088924000507","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Single room isolation for respiratory viral infections (RVI), like influenza, puts hospitals under pressure. During the influenza season 2019/20, we implemented Droplet precautions on-site (DroPS) for RVI in two acute care hospitals and prospectively assessed the rate of hospital-acquired RVI (HARVI). 318 patients were admitted with RVI, 85 had Influenza or RSV, 75 stayed in multi-bed rooms with DroPS. From 764 patients at risk, hospitalised ≥ three days in a multi-bed room, 11 (1.4%) developed a clinical HARVI, and three tested positive (3/764, 0.4%; 2x RSV, 1x influenza). DroPS may represent an alternative strategy to deal with respiratory viral infections.

查看原文本刊更多论文

现场采用飞沫预防措施（DroPS）时医院获得性呼吸道病毒感染--2019/20流感季节前瞻性观察，瑞士伯尔尼

呼吸道病毒感染（RVI）（如流感）的单间隔离给医院带来了压力。在2019/20流感季节，我们在两家急症医院针对RVI实施了现场飞沫预防措施（DroPS），并对医院获得性RVI（HARVI）的发生率进行了前瞻性评估。318 名患者因 RVI 入院，其中 85 人患有流感或 RSV，75 人住在采用 DroPS 的多床位病房。在 764 名住院时间≥ 3 天的高危患者中，11 人（1.4%）出现了临床 HARVI，3 人检测呈阳性（3/764，0.4%；2 人感染 RSV，1 人感染流感）。DroPS 可能是应对呼吸道病毒感染的另一种策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infection Prevention in Practice Medicine-Public Health, Environmental and Occupational Health

CiteScore

4.80

自引率

0.00%

发文量

审稿时长

61 days